在线日韩日本国产亚洲丨少妇伦子伦情品无吗丨欧美性猛交xxxx免费看蜜桃丨精品人妻系列无码一区二区三区丨亚洲精品无码不卡在线播放

Your Good Partner in Biology Research

DMD Recombinant Monoclonal Antibody

  • 中文名稱:
    DMD重組抗體
  • 貨號:
    CSB-RA271553A0HU
  • 規格:
    ¥1320
  • 圖片:
    • IHC image of CSB-RA271553A0HU diluted at 1:100 and staining in paraffin-embedded human heart tissue performed on a Leica BondTM system. After dewaxing and hydration, antigen retrieval was mediated by high pressure in a citrate buffer (pH 6.0). Section was blocked with 10% normal goat serum 30min at RT. Then primary antibody (1% BSA) was incubated at 4℃ overnight. The primary is detected by a Goat anti-rabbit IgG polymer labeled by HRP and visualized using 0.05% DAB.
    • IHC image of CSB-RA271553A0HU diluted at 1:100 and staining in paraffin-embedded human skeletal muscle tissue performed on a Leica BondTM system. After dewaxing and hydration, antigen retrieval was mediated by high pressure in a citrate buffer (pH 6.0). Section was blocked with 10% normal goat serum 30min at RT. Then primary antibody (1% BSA) was incubated at 4℃ overnight. The primary is detected by a Goat anti-rabbit IgG polymer labeled by HRP and visualized using 0.05% DAB.
  • 其他:

產品詳情

  • 產品描述:
    CSB-RA271553A0HU DMD重組單克隆抗體是經ELISA和免疫組化(IHC)驗證的高特異性科研用抗體,靶向抗肌萎縮蛋白(Dystrophin)。該蛋白由DMD基因編碼,是維持骨骼肌和心肌細胞膜完整性的關鍵結構蛋白,其功能缺陷與杜氏肌營養不良癥(DMD)及貝克型肌營養不良癥(BMD)的發生密切相關。本抗體通過重組技術制備,具有優異的批次穩定性和抗原結合一致性,在IHC實驗中推薦使用1:50-1:200稀釋比例,可清晰顯示目標蛋白在肌肉組織中的定位及表達水平變化。其驗證數據表明,該抗體在多種實驗體系中均表現出低背景和高信噪比特性,適用于肌肉病理機制研究、疾病模型分析以及抗肌萎縮蛋白表達調控等相關領域的基礎科研,為探索DMD基因功能及關聯疾病的分子機制提供可靠檢測工具。
  • Uniprot No.:
  • 基因名:
  • 別名:
    Dystrophin, DMD
  • 反應種屬:
    Human
  • 免疫原:
    A synthesized peptide derived from human Dystrophin
  • 免疫原種屬:
    Homo sapiens (Human)
  • 標記方式:
    Non-conjugated
  • 克隆類型:
    Monoclonal
  • 抗體亞型:
    Rabbit IgG
  • 純化方式:
    Affinity-chromatography
  • 克隆號:
    4B10
  • 濃度:
    It differs from different batches. Please contact us to confirm it.
  • 保存緩沖液:
    Rabbit IgG in 10mM phosphate buffered saline , pH 7.4, 150mM sodium chloride, 0.05% BSA, 0.02% sodium azide and 50% glycerol.
  • 產品提供形式:
    Liquid
  • 應用范圍:
    ELISA, IHC
  • 推薦稀釋比:
    Application Recommended Dilution
    IHC 1:50-1:200
  • Protocols:
  • 儲存條件:
    Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
  • 貨期:
    Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
  • 用途:
    For Research Use Only. Not for use in diagnostic or therapeutic procedures.

產品評價

靶點詳情

  • 功能:
    Anchors the extracellular matrix to the cytoskeleton via F-actin. Ligand for dystroglycan. Component of the dystrophin-associated glycoprotein complex which accumulates at the neuromuscular junction (NMJ) and at a variety of synapses in the peripheral and central nervous systems and has a structural function in stabilizing the sarcolemma. Also implicated in signaling events and synaptic transmission.
  • 基因功能參考文獻:
    1. Case Report: dystrophin mutation (p.1667 del Ala), resulting in Becker muscular dystrophy-associated cardiomyopathy that demonstrated the pathological features of significant fibrofatty replacement in the sub-epicardial layer of the ventricle. PMID: 30103083
    2. DMD gene mutations involving the hinge 3 region, actin-binding domain, and exons 45-49, as well as the LTBP4 IAAM haplotype, were not associated with age of left ventricular dysfunction onset inDuchenne muscular dystrophy. PMID: 29766838
    3. we found a new 9358-9359insA mutation of the dystrophy gene in a Chinese boy with muscular dystrophy and his mother PMID: 29336709
    4. Mutation spectrum analysis of DMD gene causing Duchenne/Becker muscular dystrophy in 68 families in Kuwait has been reported. PMID: 29847600
    5. Low dystrophin expression is associated with Becker and Duchenne muscular dystrophy. PMID: 29641567
    6. This study characterize the developmental profile of dystrophin expression across human brain regions to define the temporal profile of astrocytic endfoot development. PMID: 28509351
    7. A novel small mutation in the first exon-intron boundary splicing site of the DMD gene was found, in a patient with higher serum CK level in his family. This small mutation is responsible for X-linked dilated cardiomyopathy. PMID: 29901616
    8. new mutations in Duchenne muscular dystrophy/Becker muscular dystrophy patients with deletions were significantly more frequent than in those with duplications and small mutations. PMID: 28680110
    9. Ambulant and steroid naive Japanese Duchenne muscular dystrophy was shown significantly shorter than normal. In addition, Becker muscular dystrophy was slightly shorter than normal. This suggested that levels of dystrophin expression is associated with short stature. The fact that the higher incidence of the short stature was observed in Dp71 subgroup suggested a role of Dp71 in growth. PMID: 28734761
    10. Data indicate that Becker muscular dystrophy (BMD) patients carrying deletions of the rod domain of the exons in dystrophin gene. PMID: 29419852
    11. It has been concluded that patients with dystrophin "del x-51" or "del 48" mutations have mild or asymptomatic Becker muscular dystrophy, while "del 45-x" mutations cause comparatively severe weakness, and functional deterioration in 1 year. PMID: 27582364
    12. The study and validation of DMD as a new player in tumor development and as a new prognostic factor for tumor progression and survival are warranted. PMID: 27391342
    13. The entire DMD locus is dynamically transcribed by the RNA pol II; mechanisms involved in dystrophin gene expression control. PMID: 28867298
    14. suggests that Dp71-lamin B1 protein complex plays an important role for the newly identified tumor suppressive function of Dp71 PMID: 27449096
    15. Via increasing FAK in the cytoplasmic FAK-Dp71 , lamin B1 of nucleus laminB1-Dp71 complex, HBE-Dp71d and HBE-Dp71f cells alter their proliferation, migration, invasion, cell cycle and apoptosis rate induced by H2O2. PMID: 29059680
    16. Hence MyoD-transformed cells may be a good myogenic model for studying dystrophin gene expression, and native urine stem cells could be used to study the dystrophin transcript, and both diagnostic procedures and splicing modulation therapies in both patients and control subjects, without invasive and costly collection methods PMID: 27530229
    17. The de novo deletion of exons 17 to 29 of the DMD gene detected in the fetus may result in BMD or DMD. PMID: 28777860
    18. recent work demonstrating that multi-step events are required for long DMD intron removal. The role of temporary intron retention in the occurrence of alternative splicing events is also discussed. PMID: 28597072
    19. Study provides evidence that dystrophin contains multiple independent membrane-binding domains. These structurally and functionally distinctive membrane-binding domains provide a molecular framework for dystrophin to function as a shock absorber and signaling hub. PMID: 27378693
    20. ultiplex ligation-dependent probe amplification combined with next-generation sequencing was effective for detection of the mutations in dystrophin gene exons in patient with Duchenne and Becker muscular dystrophies. PMID: 27750387
    21. a very infrequently reported deletion of a single exon 48 of the dystrophin gene caused a subclinical or very mild form of Becker muscular dystrophy in nine non-consanguineous families PMID: 28247318
    22. This study describe a series of patients of Greek origin who carry a c.5068_5070delCAC mutation in the DMD gene. PMID: 27178005
    23. These data support the hypothesis that skewed XCI is involved in the onset of phenotype in DMD carriers, the X chromosome carrying the normal DMD gene being preferentially inactivated and leading to a moderate-severe muscle involvement. PMID: 27098336
    24. DMD reversion leads to somatic mosaicism in DMD patient. PMID: 26956251
    25. In this study, we focused on the phenotype of patients with BMD, who had in-frame deletion starting at exon 45 of the DMD gene, to investigate the appropriate restoration of the reading frame by exon skipping therapy PMID: 27974813
    26. It concluded that Dp71, comprising Dp71b and Dp71ab, was expressed exclusively in HEK293 cells and that Dp71ab was specifically localized to the nucleus. Our findings suggest that Dp71ab in the nucleus contributes to the diverse functions of HEK293 cells. PMID: 27109495
    27. This study aimed to provide in vitro quantitative evidence of the ability of human mesoangioblasts to restore dystrophin, in terms of protein accumulation and distribution, within myotubes derived from patients with Duchenne muscular dystrophy. PMID: 27502519
    28. In TMD patients, a novel locus at genome-wide level of significance (rs73460075, OR = 0.56, P = 3.8 x 10(-8)) in the intron of the dystrophin gene DMD (X chromosome), and a suggestive locus on chromosome 7 (rs73271865, P = 2.9 x 10(-7)) upstream of the Sp4 Transcription Factor ( SP4) gene were identified in the discovery cohort, but neither of these was replicated. PMID: 28081371
    29. As exon 44 skipping-amenable DMD has a later loss of ambulation, mutation-specific randomization and selection of placebo groups are essential for the success of clinical trials PMID: 27343068
    30. We focused on four prevalent mutated proteins deleted in RDelta45-47, RDelta45-48, RDelta45-49, and RDelta45-51, analyzing protein/membrane interactions. Mutants RDelta45-48 and RDelta45-51 led to mild pathologies and displayed a similar triple coiled-coil structure as the full-length DYS R16-21, whereas the two others, RDelta45-47 and RDelta45-49, induced more severe pathologies and showed "fractional" structures unre... PMID: 27367833
    31. The dystrophin expression plasmids described here will be useful in cell and gene therapy studies aimed at ameliorating Duchenne muscular dystrophy PMID: 28139886
    32. In Korean boys, 117 different deletions, 48 duplications, and 90 pathogenic sequence variations, including 30 novel variations, were identified. Deletions and duplications accounted for 65.4% and 13.3% of Korean dystrophinopathy, respectively, suggesting that the incidence of large rearrangements in dystrophin is similar among different ethnic groups. PMID: 27593222
    33. Detected are the expression of endogenous exons 44-56 connected mRNA transcript of the DMD using total RNAs derived from human normal skeletal muscle by reverse transcription polymerase chain reaction and identified are a total of eight types of multiple exon skipping products around the mutation hotspot. PMID: 27754374
    34. Multiplex Ligation Probe Amplification identified 56 mutations (45 deletions, 9 duplications and 2 point mutations), confirmed the clinical diagnosis in 63% (51/81) of patients and symptomatic females, established the carrier status of 54% (20/37) of females at-risk and 3 male villus samples, established an association between the most frequent deletion intron breakpoints and the abundance of dinucleotide microsatellites PMID: 27206868
    35. Thus using NGS we have identified a pathogenic DMD mutation from degraded DNA and low-level somatic mosaicism, which would have been overlooked using Sanger sequencing. PMID: 26740235
    36. Four nonsense, one frameshift and two splice site mutations as well as two missense variants have been found in dystrophin gene in Iranian Duchenne and Becker muscular dystrophy patients. PMID: 27350676
    37. Four missense mutations (p.Arg2937Gln, p.Asp882Gly, p.Lys2366Gln, and p.Arg1745His) that are known multiple-polymorphic sites were found in the coding region of the DMD gene. A hemizygous splicing mutation IVS44ds +1G-A (c.6438 +1G>A) was located in intron 44. PMID: 27421007
    38. Results provide evidence for recursive splicing in the dystrophin transcript and that the order at which introns are removed is not consecutive. PMID: 26670121
    39. DMD mutations affecting different DMD isoforms associate with characteristically abnormal scotopic ERGs and severe neurodevelopmental problems in Duchenne muscular dystrophy patients. PMID: 26081639
    40. DMD gene mutations may be suspected in girls child with persistently elevated levels of creatine kinase and scoliosis, calf hypertrophy, or myopathic pattern at electromyography. PMID: 26718981
    41. the deletion patterns and distribution characteristics of the dystrophin gene in a Chinese population of patients with Duchenne muscular dystrophy (DMD) or Becker muscular dystrophy, are reported. PMID: 26786758
    42. The range of phenotypes associated with the region Xp21 has been expanding. Mild end of the spectrum includes phenotype of the muscle cramps with myoglobinuria and isolated quadriceps myopathy, at the severe end, there are progressive muscle diseases. PMID: 25416089
    43. attention should be paid to the possibility of severe arrhythmias in the severe phenotype of Becker muscular dystrophy PMID: 26631896
    44. Males with mutations at the 3' end of the DMD gene affecting all protein isoforms have higher rates of intellectual disability and clusters of neurodevelopmental, emotional, and behavioural symptoms in Duchenne muscular dystrophy. PMID: 26365034
    45. Study determined the frequency of dystrophin gene alterations in Iranian Duchenne and Becker muscular dystrophies patients using two new proposed sets of primer pairs of M-PCR to facilitate further mutation detection in patients and their families PMID: 26081009
    46. Correlation of Utrophin Levels with the Dystrophin Protein Complex and Muscle Fibre Regeneration in Duchenne and Becker Muscular Dystrophy Muscle Biopsies. PMID: 26974331
    47. Mutations of Dystrophin and Duchenne and Becker muscular dystrophies (review). PMID: 26295289
    48. Data show that viral vector-mediated transient designer nuclease expression leads to permanent and regulated dystrophin synthesis from corrected native Duchenne muscular dystrophy (DMD) alleles. PMID: 26762977
    49. microRNAs contribute to variable dystrophin levels in muscular dystrophy. PMID: 26321630
    50. Knocking down Dp71 expression can significantly inhibit the A549 xenograft tumor growth in nude mice. PMID: 26691328

    顯示更多

    收起更多

  • 相關疾病:
    Duchenne muscular dystrophy (DMD); Becker muscular dystrophy (BMD); Cardiomyopathy, dilated, X-linked 3B (CMD3B)
  • 亞細胞定位:
    Cell membrane, sarcolemma; Peripheral membrane protein; Cytoplasmic side. Cytoplasm, cytoskeleton. Cell junction, synapse, postsynaptic cell membrane.
  • 組織特異性:
    Expressed in muscle fibers accumulating in the costameres of myoplasm at the sarcolemma. Expressed in brain, muscle, kidney, lung and testis. Most tissues contain transcripts of multiple isoforms. Isoform 15: Only isoform to be detected in heart and liver
  • 數據庫鏈接:

    HGNC: 2928

    OMIM: 300376

    KEGG: hsa:1756

    STRING: 9606.ENSP00000354923

    UniGene: Hs.495912



主站蜘蛛池模板: 玩弄少妇高潮ⅹxxxyw| 亚洲欧洲日本无在线码| 亚洲v国产v欧美v久久久久久| 精产国品一区二区三产区| 97无码精品综合| 亚洲午夜久久久无码精品网红a片| 最新欧美精品一区二区三区| 亚洲爆乳精品无码一区二区| 色婷婷久久综合中文久久蜜桃av| 亚洲精品熟女国产| 免费女上男下xx00xx00视频| 亚洲熟妇av综合网五月| 最新日韩精品中文字幕| 大地资源网第二页免费观看| 快好爽射给我视频| 日韩精品无码一区二区三区视频| 日日日日做夜夜夜夜做无码| 久久婷婷五月综合鬼色| 少妇被粗大的猛烈进出视频| 精品一区二区三区免费播放 | 无码人妻精品一区二区蜜桃网站| 无码精品a∨在线观看无广告| 天天综合网久久综合免费人成| 老熟女老太婆爽| 性按摩玩人妻hd中文字幕| 欧美性生 活18~19| 日韩精品一区二区三区在线观看l| 色香阁综合无码国产在线| 高清一区二区三区免费视频| 亚洲国产精品嫩草影院| 国产无遮挡又黄又爽免费网站| 丁香五月激情综合国产| 欧美性video高清精品| 国产亚洲综合久久系列| 日日碰狠狠躁久久躁综合小说| 香港三级韩国三级日本三级| 日本熟妇浓密毛毛多| 国产做a爰片久久毛片a片美国| 国产精品久久久| 亚洲精品成人无码中文毛片| 无码精品日韩专区|